Taizhen Liang

机构：First Affiliated Hospital of Guangzhou Medical University, Ministry of Education, State Key Laboratory of Respiratory Disease, Southern Medical University, Guangzhou Medical University

发表论文 23 篇 · 总被引 291 次 · h-index 11

代表论文

• Trilobatin as an HIV ‐1 entry inhibitor targeting the HIV ‐1 Gp41 envelope (2018 · FEBS Letters · 被引 30)
• Nanoparticles and Antiviral Vaccines (2023 · Vaccines · 被引 29)
• A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b (2019 · Biochemical Pharmacology · 被引 29)
• Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors. (2020 · Expert Opinion on Pharmacotherapy · 被引 28)
• The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation (2018 · Acta Pharmacologica Sinica · 被引 27)
• N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein (2019 · Frontiers in Pharmacology · 被引 26)